Pfizer Expects Decline in Covid-19 Drug Demand to Hurt 2026 Earnings [Yahoo! Finance]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Yahoo! Finance
The company reiterated its 2025 adjusted earnings guidance of $3 to $3.15 a share. It guided for 2025 revenue of $62 billion, compared with its previous forecast of $61 billion to $64 billion. Analysts see adjusted earnings of $3.13 a share and revenue of $62.5 billion, according to FactSet. Ford Takes $19.5 Billion Hit in Detroit's Biggest EV Bust High-Speed Traders Are Feuding Over a Way to Save 3.2 Billionths of a Second CEOs Are Learning to Live With Trump's Turn to State Capitalism Can U.S. Automakers Compete With Chinese EVs While Focusing on Gas Guzzlers? Trump Sues BBC for $10 Billion Over Documentary Editing Pfizer expects 2026 revenue of $59.5 billion to $62.5 billion and adjusted earnings of $2.80 to $3 a share. Wall Street is forecasting 2026 revenue of $61.6 billion and adjusted earnings of $3.05 a share. The company expects 2026 revenue from its Covid-19 products to be $1.5 billion lower than what it had expected in 2025, and sees a year-over-year negative
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Pfizer's modest 2026 outlook shows its big investments will take time to pay off [CNBC]CNBC
- Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know [Yahoo! Finance]Yahoo! Finance
- Replicate Bioscience Appoints Kathy Fernando, Ph.D., as Chief Business Officer [Yahoo! Finance]Yahoo! Finance
- Pfizer Reaffirms Full-Year 2025 EPS Guidance and Provides Full-Year 2026 Guidance [Yahoo! Finance]Yahoo! Finance
- Pfizer Reaffirms Full-Year 2025 EPS Guidance and Provides Full-Year 2026 GuidanceBusiness Wire
PFE
Earnings
- 11/4/25 - Beat
PFE
Sec Filings
- 12/16/25 - Form 8-K
- 12/2/25 - Form 4
- 11/21/25 - Form 8-K
- PFE's page on the SEC website